FDA.reportPublic FDA data

Hysingla ER 100 MG 24HR Extended Release Oral Tablet

RxCUI
1595766
RxNorm name
Hysingla ER 100 MG 24HR Extended Release Oral Tablet
Display name
Hysingla ER 100 MG 24HR Extended Release Oral Tablet
Full name
Hysingla ER 100 MG 24HR Extended Release Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:17

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Hysingla ERHYDROCODONE BITARTRATEKnoa Pharma LLCb7d23ac2-e776-9f62-3290-c64c2d6eb3532026-05-29Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1595766

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b7d23ac2-e776-9f62-3290-c64c2d6eb353Hysingla ER 100 MG 24HR Extended Release Oral Tablet [PSN] · Abuse-Deterrent 24 HR hydrocodone bitartrate 100 MG Extended Release Oral Tablet [Hysingla] [SBD] · Hysingla ER 100 MG 24 HR Extended Release Oral Tablet [SY]316These highlights do not include all the information needed to use HYSINGLA ® ER safely and effectively. See full prescribing information for HYSINGLA ER. HYSINGLA ® ER (hydrocodone bitartrate) extended-release tablets, for oral use, CII Initial U.S. Approval: 194320260501